Advanced Search

 

Study ID Status Title Patient Level Data
SMS30032 Completed Comparison of the efficacy, safety and quality of life benefits of inhaled salmeterol (50mcg bd from a Diskhaler) with that of sodium cromoglycate (20mg qds dry powder).
SMS30035 Completed A double-blind, three-way crossover study comparing GR33343G (Salmeterol) 25?g bd, salmeterol 50?g bd and placebo in the treatment of childhood asthma.
SMS30044 Completed A multicentre, randomised, double-blind, double-dummy, parallel-group study comparing the efficacy and safety of salmeterol 50 mg bd administered as a metered-dose inhaler and oral encapsulated ketotifen 1 mg bd in patients with mild to moderate reversible airways obstruction.
SMS30045 Completed A multicentre, double-blind, parallel group, randomised study comparing the efficacy and safety of inhaled salmeterol xinafoate 50 mg bd and beclomethasone dipropionate 500 mg bd with that of salmeterol xinafoate 100 mg bd and beclomethasone dipropionate 500 mg or…
SMS30046 Completed Effects of long-term administration of salmeterol on clinical symptoms, inhaled corticosteroid requirement and bronchial reactivity, and the effect of stopping long-term salmeterol treatment.
SMS30049 Completed A multicentre, double-blind, double-dummy, parallel group, randomised study comparing the efficacy and safety of inhaled salmeterol 50 mg (DISKHALER) administered 12 hourly and oral dose titrated sustained release theophylline administered 12 hourly in patients with reversible airways obstruction.
SMS30059 Completed A double-blind, crossover study comparing the efficacy of 50µg inhaled salmeterol administered twice daily (bd) with 100µg inhaled salmeterol administered once daily at night (nocte) and placebo in subjects with poorly controlled nocturnal asthma.
SMS30073 Completed A multi-centre, double-blind, randomised, parallel group study comparing the addition of inhaled salmeterol with an increase in the dose of inhaled fluticasone propionate in asthmatic patients on a low or intermediate dose of inhaled steroid.
SMS30076 Completed A Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Parallel-Group Clinical Trial of 4 Weeks Treatment With SEREVENT Inhalation Aerosol, 25mcg BID, 50mcg BID, and Placebo Administered via a Valved Holding Chamber With Facemask in Subjects With Asthma Aged 24 to 47 Months Study Listed on ClinicalStudyDataRequest.com
SMS30077 Completed Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Parallel Group, Multi-Center Clinical Trial of Four Weeks Treatment with SEREVENT™ Inhalation Aerosol, 25mcg BID, 50mcg BID and Placebo Administered Via a Valved-Holding Chamber with Facemask in Subjects with Symptoms of Asthma or Reactive Airways Disease Age 6 to 23 months Study Listed on ClinicalStudyDataRequest.com
SMS30078 Completed Multicentre, randomised, double-blind, cross-over trial to evaluate the tolerance of Salmeterol protective effect in the asthma of effort.
SMS40003 Completed A randomized, double-blind, double-dummy, parallel group comparison of salmeterol xinafoate inhalation powder (50mcg BID) with oral montelukast (10mg QD) in subjects with persistent asthma symptomatic on concomitant inhaled corticosteroid therapy.
SMS40004 Completed A randomized, double-blind, double-dummy, parallel group comparison of salmeterol xinafoate inhalation powder (50mcg BID) with oral montelukast (10mg QD) in subjects with persistent asthma symptomatic on concomitant inhaled corticosteroid therapy.
SMS40012 Completed Efficacy and safety of Salmeterol in patients with asthma controlled with inhaled corticosteroids
SMS40016 Completed A double-blind, double dummy, placebo controlled, randomised, cross-over, single dose study comparing the bronchodilator effects of salmeterol 50mcg with a combination bronchodilator Combivent® (ipratropium bromide and salbutamol) in subjects with chronic obstructive pulmonary disease (COPD)
SMS40026 Completed A Multi-Centre, Randomised, Double-Blind, Placebo-Controlled, Parallel-Group Study to Investigate the Effect of 12 Months Treatment With Salmeterol (50mcg bd), Delivered via the DISKUS* Inhaler, on the Incidence of Moderate and Severe Exacerbations in Subjects With Chronic Obstructive Pulmonary ...
SMS40065 Completed Efficacy and safety of long-term inhaled salmeterol and beclomethasone dipropionate in corticosteroid-naïve children with mild to moderate, chronic, stable asthma.
SMS40069 Completed Salmeterol versus other treatments in children with moderate asthma.
SMS40081 Completed A multi-centre, double-blind, randomised, parallel group study comparing the addition of inhaled salmeterol with an increase in the dose of inhaled fluticasone propionate in asthmatic patients on a low or intermediate dose of inhaled steroid.
SMS40093 Completed A multi-centre, randomised, double blind, three limbed, parallel-group study comparing the efficacy and tolerability of salmeterol xinafoate 25?g and 50?g bd with salbutamol 200?g bd given via pressurised inhalers in children with reversible airways obstruction. (Results of the final nine months ...
SMS40097 Completed Long-term treatment of chronic obstructive pulmonary disease with Salmeterol and the additive effect of Ipratropium.
SMS40099 Completed A multicentre, randomised, double-blind, parallel group study to compare the efficacy and safety of inhaled salmeterol xinafoate 50 mg bd and inhaled salmeterol xinafoate 100 mg bd with placebo, all administered via the metered-dose inhaler, in the treatment of patients with…
SMS40124 Completed Prophylactic treatment of exercise-induced asthma in children: salmeterol or sodium cromoglycate single dose before exercise
SMS40138 Completed Comparison of Salmeterol versus other usually prescribed treatments in adults with moderate to severe asthma.
SMS40180 Completed A 12 week study to compare the efficacy and safety of salmeterol xinafoate plus beclomethasone dipropionate with a double dose of beclomethasone dipropionate in patients with mild to moderate reversible airways obstruction treated by a general practitioner.

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.